Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Healthtech Industry Analysis

UpdatedOct 27, 2025
DataAggregated Company Financials
Companies70
  • 7D2.0%
  • 3M3.7%
  • 1Y26.3%
  • YTD22.4%

Over the last 7 days, the Healthtech industry has risen 2.0%, driven by gains from Veeva Systems of 2.5%. This means that the industry has gained 26% over the past year. As for the next few years, earnings are expected to grow by 21% per annum.

Industry Valuation and Performance

Has the U.S. Healthtech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 27 Oct 2025US$81.4bUS$13.1b-US$212,082,154.0059.3x-383.7x6.2x
Wed, 24 Sep 2025US$79.3bUS$13.2b-US$266,647,296.0058.9x-297.5x6x
Fri, 22 Aug 2025US$77.4bUS$13.1b-US$369,126,795.0059.1x-209.6x5.9x
Sun, 20 Jul 2025US$77.2bUS$13.2b-US$1,447,621,447.0059.1x-53.3x5.8x
Tue, 17 Jun 2025US$76.8bUS$13.2b-US$1,383,488,447.0056x-55.5x5.8x
Thu, 15 May 2025US$71.4bUS$13.1b-US$1,455,625,534.0056.5x-49.1x5.5x
Sat, 12 Apr 2025US$62.9bUS$13.2b-US$1,415,308,497.0049.7x-44.5x4.8x
Mon, 10 Mar 2025US$72.3bUS$13.1b-US$1,519,804,514.0059.6x-47.6x5.5x
Wed, 05 Feb 2025US$71.3bUS$12.9b-US$1,638,054,514.0059.9x-43.5x5.5x
Fri, 03 Jan 2025US$65.1bUS$12.9b-US$1,636,315,514.0053.8x-39.8x5.1x
Sun, 01 Dec 2024US$68.1bUS$12.8b-US$1,712,780,390.0058.4x-39.7x5.3x
Tue, 29 Oct 2024US$62.7bUS$13.6b-US$3,127,204,656.0049.2x-20x4.6x
Thu, 26 Sep 2024US$64.3bUS$14.0b-US$3,288,675,208.0052.6x-19.6x4.6x
Sat, 24 Aug 2024US$62.1bUS$13.9b-US$3,379,735,604.0059x-18.4x4.5x
Mon, 22 Jul 2024US$58.1bUS$13.7b-US$1,860,692,542.0052.6x-31.2x4.3x
Wed, 19 Jun 2024US$56.7bUS$13.7b-US$1,889,788,216.0047.1x-30x4.2x
Fri, 17 May 2024US$58.4bUS$12.8b-US$1,978,869,031.0046.6x-29.5x4.6x
Sun, 14 Apr 2024US$60.9bUS$12.7b-US$1,616,515,745.0048.4x-37.7x4.8x
Tue, 12 Mar 2024US$64.5bUS$14.1b-US$1,445,414,794.0050.2x-44.6x4.6x
Thu, 08 Feb 2024US$61.4bUS$13.8b-US$5,690,204,752.0060.9x-10.8x4.5x
Sat, 06 Jan 2024US$70.0bUS$18.3b-US$5,780,492,665.0052.7x-12.1x3.8x
Mon, 04 Dec 2023US$66.7bUS$18.2b-US$5,807,346,665.0053.2x-11.5x3.7x
Wed, 01 Nov 2023US$65.5bUS$18.1b-US$5,527,928,965.0049.4x-11.8x3.6x
Fri, 29 Sep 2023US$69.5bUS$18.0b-US$5,514,972,389.0051.8x-12.6x3.9x
Sun, 27 Aug 2023US$69.5bUS$17.9b-US$5,554,149,562.0051.9x-12.5x3.9x
Tue, 25 Jul 2023US$76.8bUS$17.7b-US$8,580,548,318.0060.5x-8.9x4.3x
Thu, 22 Jun 2023US$76.1bUS$17.7b-US$8,580,509,261.0062.8x-8.9x4.3x
Sat, 20 May 2023US$68.8bUS$17.7b-US$8,626,979,320.0058.8x-8x3.9x
Mon, 17 Apr 2023US$73.0bUS$17.4b-US$14,978,932,055.0057x-4.9x4.2x
Wed, 15 Mar 2023US$70.6bUS$17.7b-US$15,404,160,403.0052.4x-4.6x4x
Fri, 10 Feb 2023US$73.6bUS$17.5b-US$10,804,200,563.0050.8x-6.8x4.2x
Sun, 08 Jan 2023US$66.4bUS$17.5b-US$10,803,491,310.0042.6x-6.1x3.8x
Tue, 06 Dec 2022US$71.3bUS$17.5b-US$10,602,609,310.0049.4x-6.7x4.1x
Thu, 03 Nov 2022US$67.2bUS$17.2b-US$10,559,547,342.0033.6x-6.4x3.9x
Price to Earnings Ratio

-6.4x


Total Market Cap: US$67.2bTotal Earnings: -US$10,559,547,342.00Total Revenue: US$17.2bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthtech Industry Price to Earnings3Y Average -45x202320242025
Current Industry PE
  • Investors are optimistic on the American Healthcare Services industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 4.6x is lower than the industry's current PS ratio of 6.2x.
Past Earnings Growth
  • The earnings for companies in the Healthcare Services industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 8.7% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market1.01%
Healthcare0.87%
Healthtech2.05%
Healthtech2.05%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
VEEV Veeva SystemsUS$293.022.5%
+US$1.2b		38.1%PE59.3x
WAY Waystar HoldingUS$38.975.4%
+US$383.7m		39.7%PE86.6x
CTEV ClaritevUS$69.6926.1%
+US$237.7m		619.2%PS1.2x
HTFL HeartFlowUS$37.878.0%
+US$235.9m		n/aPS21.3x
TDOC Teladoc HealthUS$9.465.3%
+US$84.8m		3.1%PS0.7x

Latest News

HTFL
US$37.87
HeartFlow
7D
8.0%
1Y
n/a
TDOC
US$9.46
Teladoc Health
7D
5.3%
1Y
3.1%
DH
US$2.97
Definitive Healthcare
7D
-2.3%
1Y
-29.6%
CERT
US$12.66
Certara
7D
2.8%
1Y
21.5%

Analysts Maintain Certara Price Target as Pharma Sector Recovery and New Developments Drive Outlook

Analysts have maintained their price target for Certara at $14.75, citing the company’s positioning at the center of a recovering pharma and biotech sector as a key reason for their continued positive outlook. Analyst Commentary Bullish Takeaways Bullish analysts highlight Certara's central position in the anticipated rebound of the pharma and biotech sectors.
CTEV
US$69.69
Claritev
7D
26.1%
1Y
619.2%

Analysts Boost Claritev Valuation Amid Growth Optimism and Strategic Developments

Analysts have raised Claritev's fair value estimate from $70.50 to $80.00. They cite growing confidence in the company's accelerated revenue growth outlook and sustained margins following the recent price target upgrade.
SLP
US$17.83
Simulations Plus
7D
15.8%
1Y
-41.9%
SDGR
US$22.52
Schrödinger
7D
2.5%
1Y
22.6%
HSTM
US$26.31
HealthStream
7D
-2.5%
1Y
-9.1%
DOCS
US$66.84
Doximity
7D
-1.7%
1Y
61.4%

AI Integration And Telehealth Expansion Will Transform The Healthcare Industry

Analysts have raised their price target for Doximity from $69.50 to $70.72. They cited slightly improved profit margin forecasts and increased confidence in the company’s platform engagement as advertising trends evolve.
GDRX
US$3.95
GoodRx Holdings
7D
-0.8%
1Y
-37.8%
WAY
US$38.97
Waystar Holding
7D
5.4%
1Y
39.7%
CCLD
US$3.25
CareCloud
7D
-1.8%
1Y
32.7%
VEEV
US$293.02
Veeva Systems
7D
2.5%
1Y
38.1%

IQVIA Resolution And Embedded AI Will Expand Digital Healthcare Cloud

Narrative Update on Veeva Systems: Analyst Price Target Revision Analysts have raised their fair value estimate for Veeva Systems to approximately $321 per share, up by nearly $4. They cited stronger than expected sales momentum, driven by new major customer commitments and continued growth in key business segments.
BFRG
US$1.42
Bullfrog AI Holdings
7D
-5.3%
1Y
-41.8%
AMWL
US$5.57
American Well
7D
-0.7%
1Y
-43.9%
AIFF
US$2.08
Firefly Neuroscience
7D
-17.1%
1Y
-42.2%